Literature DB >> 7369406

Psychosocial aspects of neoplastic disease: II. Affective and cognitive effects of chemotherapy in cancer patients.

P M Silberfarb, D Philibert, P M Levine.   

Abstract

A battery of cognitive and affective tests administered to 50 consecutively admitted medical oncology patients revealed cognitive impairment to be a common occurrence in the absence of affective disorders or other psychopathology. Chemotherapy was the major variable associated with cognitive impairment in these patients. These findings suggest that the consultant psychiatrist should be aware of chemotherapy as a possible source of behavioral change and emotional distress in cancer patients.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7369406     DOI: 10.1176/ajp.137.5.597

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


  18 in total

Review 1.  Delirium in hospitalized elderly.

Authors:  J Francis; W N Kapoor
Journal:  J Gen Intern Med       Date:  1990 Jan-Feb       Impact factor: 5.128

Review 2.  Cancer 'survivor-care': I. the α7 nAChR as potential target for chemotherapy-related cognitive impairment.

Authors:  R B Raffa
Journal:  J Clin Pharm Ther       Date:  2010-08-24       Impact factor: 2.512

Review 3.  Cancer 'survivor-care': II. Disruption of prefrontal brain activation top-down control of working memory capacity as possible mechanism for chemo-fog/brain (chemotherapy-associated cognitive impairment).

Authors:  R B Raffa
Journal:  J Clin Pharm Ther       Date:  2013-05-08       Impact factor: 2.512

4.  Do Patients With Advanced Cancer Have the Ability to Make Informed Decisions for Participation in Phase I Clinical Trials?

Authors:  Fay J Hlubocky; Greg A Sachs; Eric R Larson; Halla S Nimeiri; David Cella; Kristen E Wroblewski; Mark J Ratain; Jeffery M Peppercorn; Christopher K Daugherty
Journal:  J Clin Oncol       Date:  2018-07-09       Impact factor: 44.544

Review 5.  Clearing the fog: a review of the effects of dietary omega-3 fatty acids and added sugars on chemotherapy-induced cognitive deficits.

Authors:  Tonya S Orchard; Monica M Gaudier-Diaz; Kellie R Weinhold; A Courtney DeVries
Journal:  Breast Cancer Res Treat       Date:  2016-12-08       Impact factor: 4.872

6.  A proposed mechanism for chemotherapy-related cognitive impairment ('chemo-fog').

Authors:  R B Raffa
Journal:  J Clin Pharm Ther       Date:  2010-08-24       Impact factor: 2.512

Review 7.  Potential Use of Nicotinic Receptor Agonists for the Treatment of Chemotherapy-Induced Cognitive Deficits.

Authors:  Rex M Philpot
Journal:  Neurochem Res       Date:  2015-02-05       Impact factor: 3.996

Review 8.  Low neuropsychologic performance among adult cancer survivors treated with chemotherapy.

Authors:  Robert J Ferguson; Tim A Ahles
Journal:  Curr Neurol Neurosci Rep       Date:  2003-05       Impact factor: 5.081

9.  Cognitive and psychological factors associated with early posttreatment functional outcomes in breast cancer survivors.

Authors:  Stephanie A Reid-Arndt; Albert Yee; Michael C Perry; Catherine Hsieh
Journal:  J Psychosoc Oncol       Date:  2009

10.  Effects of chemotherapeutic agents 5-fluorouracil and methotrexate alone and combined in a mouse model of learning and memory.

Authors:  John J Foley; Robert B Raffa; Ellen A Walker
Journal:  Psychopharmacology (Berl)       Date:  2008-05-08       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.